5171 - 5180 of 8818 Results
Title
Year
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 69
-
RESTRICTEDTitle: What’s the target: understanding two decades of in silico microRNA-target predictionJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 6Start Page: 1999End Page: 2010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/bib/bbz111Citation Count: 51
-
OPENTitle: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201800108Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6283072Citation Count: 66
-
RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27
-
RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
RESTRICTEDTitle: Utilising functional MRI (fMRI) to explore the freezing phenomenon in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 18Issue #: 6Start Page: 807End Page: 810Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2011.02.003Citation Count: 36
-
OPENTitle: Sex differences in LRRK2 G2019S and idiopathic Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 11Start Page: 801End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.489Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.489Citation Count: 35
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 66
-
OPENTitle: Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 18Start Page: 3487End Page: 3496Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00536Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00536Citation Count: 22
-
OPENTitle: Postmortem Interval Influencesα-Synuclein Expression in Parkinson Disease BrainJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/614212Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/614212.pdfCitation Count: 12